Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 dose-ranging study of INO-4500 in healthy volunteers in Ghana
PACTR201910864382850Phase 1Recruiting
- Sponsor
- Inovio Pharmaceuticals, Inc.
- Start
- Jan 2021
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 1 trial of INO-4500 in Lassa fever (4 arms), sponsored by Inovio Pharmaceuticals, Inc. Started Jan 2021; status: recruiting.
02
Drugs
INO-4500
03
Conditions
Lassa fever
Beyond the preview
Go deeper on PACTR201910864382850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201910864382850.